• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Biotricity Inc (NQ: BTCY )

    1.100 -0.040 (-3.51%)
    Streaming Delayed Price Updated: 4:00 PM EDT, May 30, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 313,052
    Open 1.290
    Bid (Size) 1.070 (4)
    Ask (Size) 1.090 (6)
    Prev. Close 1.140
    Today's Range 1.090 - 1.300
    52wk Range 0.7007 - 4.271
    Shares Outstanding 9,258,957
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Biotricity Announces the Upcoming Launch of the First-Ever Direct-to-Patient Cardiac Screening Service, Targeting the $1.05B Home Heart Health Market
    Via ACCESSWIRE
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga

    Performance

    YTD
    -6.80%
    -6.80%
    1 Month
    -20.86%
    -20.86%
    3 Month
    +4.76%
    +4.76%
    6 Month
    +18.97%
    +18.97%
    1 Year
    -73.97%
    -73.97%

    More News

    Read More
    Biotricity Expands Market Reach to Pulmonary and Neurology Fields Through Latest Partnerships with Two Leading Home-Based Diagnostic Companies
    Via ACCESSWIRE
    Biotricity's Path Towards Breakeven Accelerated by Latest Diagnostic Product, Biotres Pro, Garnering Rapid Interest from Existing and New Customers
    Via ACCESSWIRE
    Biotricity Receives Health Canada Clearance for Biotres
    Via ACCESSWIRE
    Biotricity's Earnings Outlook
    Via Benzinga
    Biotricity Expands Development of its Cardiac AI Cloud Platform with Data Ecosystem of over 360 billion Heartbeats
    Via ACCESSWIRE
    Biotricity Launches Major Cardiac Monitoring Pilot Program in a Hospital System Comprised of 9 Hospitals and 10 Clinics
    Via ACCESSWIRE
    Biotricity Launches Cardiac Monitoring Pilot Program with Major Hospital Network
    Via ACCESSWIRE
    Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    Earnings Outlook For Biotricity
    Via Benzinga
    Biotricity Announces a Strategic Partnership for Cardiac Screenings in Patients with Co-Morbidities
    Via ACCESSWIRE
    LOBO EV and Biotricity Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
    Via ACCESSWIRE
    Biotricity Accelerates Market Access by Partnering with Third Major Group Purchasing Organization, Expanding Market Reach to 90% of U.S. Hospitals
    Via ACCESSWIRE
    Biotricity Partners with Health Aid Africa to Provide Complementary Heart Health Screenings at Allegiant Stadium Concert
    Via ACCESSWIRE
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Biotricity Unveils that Improved Margins Resulted from Latest Advancements to its Proprietary Cardiac AI Cloud Platform and Announces Plans for Continued Expansion of its Cardiac AI Cloud
    Via ACCESSWIRE
    Biotricity Partners with a Second Top Group Purchasing Organization - Positions Company for Expanded Market Access to 1 out of every 2 Hospitals in America
    Via ACCESSWIRE
    Biotricity Strengthens its Foundation for Growth, Achieves Lower Cost of Sales, Expanding Margins of 73% and Increased Device Sales, for Third Quarter of Fiscal Year 2024
    Via ACCESSWIRE
    Biotricity to Host Third Quarter Fiscal Year 2024 Financial Results and Business Update Call on February 21st
    Via ACCESSWIRE
    Why Fluor Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Biotricity Advances Towards Breakeven Milestone - Set to Announce Record Margins and Operational Efficiency for Third Quarter of Fiscal Year 2024
    Via ACCESSWIRE
    Earnings Scheduled For February 20, 2024
    Via Benzinga
    Biotricity Delivers Record Margins and Double Digit Year-Over-Year Sales Growth for Second Quarter of Fiscal Year 2024
    Via ACCESSWIRE
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.